Corporate, Portfolio & Brand Strategy

As the industry has evolved, market interactions have become increasingly complex, with high degrees of inter-dependencies across diverse stakeholders (physicians, patients, payers, regulators, pharmaceutical manufacturers). We leverage the expertise in our Market Research and Analytics Centers of Excellence to mine and integrate insights across stakeholders and geographies. CRA helps clients understand, not just the current market dynamics, but more importantly, how the market will evolve and how to develop and commercialize your asset to maximize success.

CRA supports clients in evaluating the opportunities and risks to inform “go-no-go” decisions and business development decisions. We take a holistic approach and partner with clinical, commercial, access, and policy teams, to deliver an integrated assessment of the opportunity. We work closely with clients to develop tailored forecasts across different scenarios to assess and plan for market uncertainties. Our recommendations are built upon a strong foundation of evidence and analytics balanced with CRA’s industry and market expertise.

CRA partners with clients to develop their commercial strategy across the product lifecycle, from early stage commercial planning through launch preparation and beyond to life cycle management. We collaborate with clients to develop agile, robust strategies that can keep pace with the ever-changing healthcare industry. We help clients create their positioning and brand identity, build and implement a robust go-to-market strategy, and track launch performance. CRA brings to the table a wealth of experience supporting successful product launches across a wide spectrum of therapeutic areas, including acute and chronic disorders, oncology, and rare disease.

Strong medical and scientific innovation is at the core of every successful organization.  Understanding how to leverage and strategically communicate these innovations is what sets you apart from your competitors. From informing clinical development strategies and real-world evidence generation plans to constructing innovative strategies for engaging with customers and advocacy groups, CRA has a unique combination of scientific, medical, and analytic expertise to provide support across the full spectrum of client needs.

Considering developmental timelines and investment demands, optimizing portfolio strategy can be among the most critical decisions made by an organization.  Whether you are looking to further establish and build on strengths, or you are looking to redefine core areas of focus, CRA has the unparalleled expertise and experience to guide you to the right decisions.  We have an established process to identify and evaluate opportunities with high potential, while also fitting in to your business structure.  Driven by our Market Research and Analytics Centers of Excellence, we are uniquely positioned to uncover the most valuable insights, and provide guidance no matter the scope, or turnaround time needed.

Our global experts in life sciences support Medical Affairs teams in developing and implementing their strategies to optimize their role as key function and interface between pharma manufacturers and the scientific community, to ultimately have a positive impact on patient outcomes.  CRA supports Medical Affairs teams with:

• Guided medical affairs strategy
• Understanding physician and patient needs
• Facilitating and strengthening internal collaboration
• Creating knowledge
• Positively impacting patient outcomes